Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast vs. Salmeterol for Exercise-Induced Bronchoconstriction in Children
NCT00127166Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2005
- Primary completion
- Nov 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of montelukast, salmeterol in Exercise-induced bronchoconstriction (EIB), sponsored by Organon & Co.. Started Dec 2005; status: completed.
02
Drugs
montelukastsalmeterol
03
Conditions
Exercise-induced bronchoconstriction (EIB)
Beyond the preview
Go deeper on NCT00127166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127166.